1. Home
  2. IHS vs PRGO Comparison

IHS vs PRGO Comparison

Compare IHS & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IHS Holding Limited

IHS

IHS Holding Limited

HOLD

Current Price

$7.62

Market Cap

2.5B

ML Signal

HOLD

Logo Perrigo Company plc

PRGO

Perrigo Company plc

HOLD

Current Price

$14.90

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IHS
PRGO
Founded
2001
1887
Country
United Kingdom
Ireland
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
2021
1991

Fundamental Metrics

Financial Performance
Metric
IHS
PRGO
Price
$7.62
$14.90
Analyst Decision
Buy
Buy
Analyst Count
7
3
Target Price
$9.32
$20.33
AVG Volume (30 Days)
1.1M
4.2M
Earning Date
11-12-2025
02-26-2026
Dividend Yield
N/A
7.70%
EPS Growth
N/A
N/A
EPS
1.37
N/A
Revenue
$1,765,825,000.00
$4,281,800,000.00
Revenue This Year
$3.49
N/A
Revenue Next Year
$2.77
N/A
P/E Ratio
$5.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.02
$12.17
52 Week High
$8.21
$30.93

Technical Indicators

Market Signals
Indicator
IHS
PRGO
Relative Strength Index (RSI) 54.81 59.35
Support Level $7.34 $13.78
Resistance Level $8.21 $15.21
Average True Range (ATR) 0.27 0.40
MACD 0.02 0.19
Stochastic Oscillator 45.54 75.72

Price Performance

Historical Comparison
IHS
PRGO

About IHS IHS Holding Limited

IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, the Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Share on Social Networks: